Form 4 for TMO Thermo Fisher Scientific
Accepted 2024-08-27 00:00:00 ET · period of report 2024-08-23 · accession 0001127602-24-022979 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-08-27 | 2024-08-23 | TMO | Lagarde Michel | EVP, COO | F - Tax | $606.12 | -504.29 | 17.6K | -3% | -$305.7K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-08-23 | F | D | 504.29 | $606.12 | 17,629.95 | D | — | — |